Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Mol Biosyst. 2016 Jan;12(1):169–177. doi: 10.1039/c5mb00524h

Table 1. Summary of inhibitory action of DMs and controls.

Inhibitor Residue / Charge ATPase50 [a] (μM) / (Relative activity) scDNA50[b] (μM)
DM1* 29 / –11 95.2±7.0 (512) 172.6±3.9
DM1-SS-DM1 60 / –22 22.5±0.2 (121) 38.0±0.9
DM2-SS-DM2 62 / –22 36.1±0.2 (194) 63.9±0.7
DMscr-SS-DMscr 62 / –22 182±13.4 (978) 612.0±19.5
DMc-SS-DMc 62 / –22 237.3±13.4 (1276) 245.5±14.7
Ocr99 99 / –18 0.186±0.004 (1) 0.172±0.011
T7 Ocr 14 / –7 not active not active
R46 ArdA 14 / –2 not active not active
[a]

Half maximal ATPase activity inhibition (ATPase50) represents the peptide concentration at which 50% of ATPase activity of the enzyme is inhibited. ATPase50 values were calculated by fitting a straight line to the average relative rate vs. peptide concentration data (n≥3).

[b]

Peptide concentration at which 50% of total scDNA. scDNA50 was determined by fitting %scDNA vs. peptide concentration obtained from densitometric analysis of agarose gels (n≥3). The data is represented as mean±SEM.

*

No N-terminal cysteine residue.